Skip to content

Eastman Kodak Company KODK Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

Centerspace logo
CenterspaceCSR
$43K-93.9%
Empire State Realty Trust logo
Empire State Realty TrustESRT
$5.99M+278%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$28.57M
Macerich logo
MacerichMAC
$5.23M+4,335%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$52.83M
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$126.92M

Other financials

Income statement

See full
Revenue$265.0M+7.3%
Gross profit$57.0M+23.9%
Operating income-$1.0M+92.3%
Net income-$16.0M-129%
EPS (diluted)-$0.21-75.0%

Balance sheet

See full
Cash & equivalents$299.0M+89.2%
Total debt$198.0M-61.1%
Total equity$600.0M+6.6%
Total assets$1.6B-19.6%

Cash flow

See full
Operating cash flow-$30.0M+21.1%
CapEx$6.0M-50.0%
Free cash flow-$36.0M+28.0%

Valuation

See full
Market cap$906.7M+97.6%
Enterprise value$805.7M-0.5%
P/S0.8×+0.4×

Profitability

See full
Gross margin22.4%+3.1pp
Operating margin1.1%+0.6pp
Net margin-12.6%-18.7pp
FCF margin42.3%+34.9pp

Returns & leverage

See full
Return on equity-23.6%-31.9pp
Debt / equity0.3×-0.6×
Current ratio2.5×+0.3×

Where this comes from

Reported directly by Eastman Kodak Company in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: Eastman Kodak Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eastman Kodak Company's exchange offer (note 12).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eastman Kodak Company's exchange offer (note 12)?
Eastman Kodak Company (KODK) reported exchange offer (note 12) of $30M in Q1 2026.
What does exchange offer (note 12) mean?
This metric represents the total value of debt or other financial instruments converted into common equity during the reporting period. It reflects non-cash financing activities that alter the company's capital structure by reducing liabilities and increasing shareholder equity. Investors monitor this to assess the impact of balance sheet restructuring and potential dilution to existing shareholders.